164 related articles for article (PubMed ID: 1315166)
1. Anti-HCV antibody in Chinese cirrhotic patients with or without hepatocellular carcinoma: relation to multitransfusion.
Chang WY; Wang LY; Chuang WL; Chen SC; Lu SN; You SL
J Gastroenterol Hepatol; 1992; 7(2):128-31. PubMed ID: 1315166
[TBL] [Abstract][Full Text] [Related]
2. Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features.
Farinati F; Fagiuoli S; De Maria N; Chiaramonte M; Aneloni V; Ongaro S; Salvagnini M; Naccarato R
J Hepatol; 1992 Mar; 14(2-3):183-7. PubMed ID: 1380021
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
Tomimatsu M; Ishiguro N; Taniai M; Okuda H; Saito A; Obata H; Yamamoto M; Takasaki K; Nakano M
Cancer; 1993 Aug; 72(3):683-8. PubMed ID: 8192727
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study.
Tsai JF; Chang WY; Jeng JE; Ho MS; Lin ZY; Tsai JH
Liver; 1994 Apr; 14(2):98-102. PubMed ID: 7515142
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma.
Colombo M; Rumi MG; Donato MF; Tommasini MA; Del Ninno E; Ronchi G; Kuo G; Houghton M
Dig Dis Sci; 1991 Aug; 36(8):1130-3. PubMed ID: 1650689
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of hepatitis B and C viral markers in Japanese patients with hepatocellular carcinoma.
Tanaka N; Chiba T; Matsuzaki Y; Osuga T; Aikawa T; Mitamura K
Gastroenterol Jpn; 1993 Aug; 28(4):547-53. PubMed ID: 7690725
[TBL] [Abstract][Full Text] [Related]
8. Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma.
Tong MJ; Lee SY; Hwang SJ; Co RL; Lai PP; Chien D; Kuo G
West J Med; 1994 Feb; 160(2):133-8. PubMed ID: 7512778
[TBL] [Abstract][Full Text] [Related]
9. The role of hepatitis C virus in chronic hepatitis B virus infection.
Chuang WL; Chang WY; Lu SN; Lin ZY; Chen SC; Hsieh MY; Wang LY; You SL; Chen CJ
Gastroenterol Jpn; 1993 May; 28 Suppl 5():23-7. PubMed ID: 7689504
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection in chronic liver disease in Natal.
Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
[TBL] [Abstract][Full Text] [Related]
11. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study.
Chuang WL; Chang WY; Lu SN; Su WP; Lin ZY; Chen SC; Hsieh MY; Wang LY; You SL; Chen CJ
Cancer; 1992 Apr; 69(8):2052-4. PubMed ID: 1311978
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibody against the core protein of hepatitis C virus in patients with hepatocellular carcinoma.
Watanabe Y; Harada S; Saito I; Miyamura T
Int J Cancer; 1991 May; 48(3):340-3. PubMed ID: 1710205
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
Simonetti RG; Cammà C; Fiorello F; Cottone M; Rapicetta M; Marino L; Fiorentino G; Craxì A; Ciccaglione A; Giuseppetti R
Ann Intern Med; 1992 Jan; 116(2):97-102. PubMed ID: 1309286
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma.
Lee SD; Lee FY; Wu JC; Hwang SJ; Wang SS; Lo KJ
Cancer; 1992 Jan; 69(2):342-5. PubMed ID: 1309428
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus detection is facilitated by the combined use of c100 protein and GOR epitope.
Hayashi J; Nakashima K; Hirata M; Noguchi A; Akazawa K; Maeda Y; Kashiwagi S
Gastroenterol Jpn; 1992 Oct; 27(5):632-7. PubMed ID: 1385249
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
Yu ZY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic.
Tsega E; Nordenfelt E; Hansson BG
Trans R Soc Trop Med Hyg; 1995; 89(2):171-4. PubMed ID: 7539952
[TBL] [Abstract][Full Text] [Related]
18. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus-positive cirrhotic patients.
Tarao K; Ohkawa S; Shimizu A; Harada M; Nakamura Y; Ito Y; Tamai S; Hoshino H; Inoue T; Kanisawa M
Cancer; 1994 Feb; 73(4):1149-54. PubMed ID: 7508816
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience.
Chen DS; Kuo GC; Sung JL; Lai MY; Sheu JC; Chen PJ; Yang PM; Hsu HM; Chang MH; Chen CJ
J Infect Dis; 1990 Oct; 162(4):817-22. PubMed ID: 2169497
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection in African patients with liver cirrhosis or primary hepatocellular carcinoma.
Mets T; Smitz J; Ngendahayo P; Sabbe L; Bigilimana I; Ngirabatware B
Scand J Gastroenterol; 1993 Apr; 28(4):331-4. PubMed ID: 8387695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
